LabCorp
LH
$214.51
Share price
0.61%
Change (1 day)
-3.76%
Change (1 year)
Categories
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.
LabCorp (LH) - Total debt
Total debt on the balance sheet as of March 2024 : $5.96 B
According to LabCorp's latest financial reports the company's total debt is $5.96 B. A company’s total debt is the sum of all current and non-current debts.
LabCorp - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $5.95 B | -4.68% |
| 2022-12-31 | $6.24 B | -1.52% |
| 2021-12-31 | $6.34 B | -6.12% |
| 2020-12-31 | $6.75 B | -4.94% |
| 2019-12-31 | $7.10 B | 17.29% |
| 2018-12-31 | $6.05 B | -10.39% |
| 2017-12-31 | $6.76 B | 15.6% |
| 2016-12-31 | $5.84 B | -8.09% |
| 2015-12-31 | $6.36 B | 110.05% |
| 2014-12-31 | $3.02 B | 0.98% |
| 2013-12-31 | $3.00 B | 13.01% |
| 2012-12-31 | $2.65 B | 19.54% |
| 2011-12-31 | $2.22 B | 1.49% |
| 2010-12-31 | $2.18 B | 56.94% |
| 2009-12-31 | $1.39 B | -18.99% |
| 2008-12-31 | $1.72 B | 3.26% |
| 2007-12-31 | $1.66 B | 44.03% |
| 2006-12-31 | $1.15 B | 0.72% |
| 2005-12-31 | $1.14 B | 29.2% |
| 2004-12-31 | $0.88 B | 0.59% |
| 2003-12-31 | $0.88 B | 69.42% |
| 2002-12-31 | $0.52 B | 2.55% |
| 2001-12-31 | $0.50 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 IDEXX Laboratories IDXX | $1.06 B | -82.09% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $5.35 B | -10.33% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | N/A | N/A | 🇺🇸 USA |
 NeoGenomics
NEO | $0.60 B | -89.81% | 🇺🇸 USA |
 Qiagen QGEN | $1.50 B | -74.81% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $7.18 M | -99.88% | 🇺🇸 USA |